STERIS plc (STE)
NYSE: STE · Real-Time Price · USD
237.93
+2.19 (0.93%)
Aug 21, 2026, 4:00 PM EDT - Market closed
STERIS Revenue
STERIS had revenue of $1.49B in the quarter ending June 30, 2026, with 7.30% growth. This brings the company's revenue in the last twelve months to $6.04B, up 8.37% year-over-year. In the fiscal year ending March 31, 2026, STERIS had annual revenue of $5.94B with 8.73% growth.
Revenue (ttm)
$6.04B
Revenue Growth
+8.37%
P/S Ratio
3.84
Revenue / Employee
$336,595
Employees
17,937
Market Cap
23.20B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 5.94B | 476.40M | 8.73% |
| Mar 31, 2025 | 5.46B | 320.80M | 6.24% |
| Mar 31, 2024 | 5.14B | 602.43M | 13.28% |
| Mar 31, 2023 | 4.54B | 312.86M | 7.41% |
| Mar 31, 2022 | 4.22B | 1.12B | 35.91% |
| Mar 31, 2021 | 3.11B | 76.62M | 2.53% |
| Mar 31, 2020 | 3.03B | 248.73M | 8.94% |
| Mar 31, 2019 | 2.78B | 162.17M | 6.19% |
| Mar 31, 2018 | 2.62B | 7.24M | 0.28% |
| Mar 31, 2017 | 2.61B | 373.99M | 16.71% |
| Mar 31, 2016 | 2.24B | 388.50M | 21.00% |
| Mar 31, 2015 | 1.85B | 228.01M | 14.06% |
| Mar 31, 2014 | 1.62B | 120.35M | 8.01% |
| Mar 31, 2013 | 1.50B | 95.09M | 6.76% |
| Mar 31, 2012 | 1.41B | 199.36M | 16.51% |
| Mar 31, 2011 | 1.21B | -50.29M | -4.00% |
| Mar 31, 2010 | 1.26B | -40.79M | -3.14% |
| Mar 31, 2009 | 1.30B | 33.44M | 2.64% |
| Mar 31, 2008 | 1.27B | 67.68M | 5.65% |
| Mar 31, 2007 | 1.20B | 37.12M | 3.20% |
| Mar 31, 2006 | 1.16B | 78.61M | 7.27% |
| Mar 31, 2005 | 1.08B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| GE HealthCare Technologies | 21.27B |
| Koninklijke Philips | 20.18B |
| Zimmer Biomet Holdings | 8.51B |
| Edwards Lifesciences | 6.51B |
| Smith & Nephew | 6.30B |
| DexCom | 4.97B |
| Globus Medical | 3.14B |
| Insulet | 3.05B |
STE News
- 14 days ago - Steris price target lowered to $270 from $275 at UBS - TheFly
- 15 days ago - STERIS Earnings Call Transcript: Q1 2027 - Transcripts
- 15 days ago - STERIS Earnings release: Q1 2027 - Filings
- 15 days ago - STERIS Quarterly report: Q1 2027 - Filings
- 16 days ago - Steris announces targeted restructuring plan - TheFly
- 16 days ago - Steris reports Q1 adjusted EPS $2.59, consensus $2.49 - TheFly
- 16 days ago - Steris backs FY27 adjusted EPS view of $11.10-$11.30, consensus $11.16 - TheFly
- 16 days ago - STERIS Announces Financial Results for Fiscal 2027 First Quarter - GlobeNewsWire